Literature DB >> 26898658

Gut Microbiota of Nonalcoholic Fatty Liver Disease.

Reham M Abdou1, Lixin Zhu2,3, Robert D Baker2, Susan S Baker2.   

Abstract

The prevalence of nonalcoholic fatty liver disease has been rapidly increasing worldwide. It has become a leading cause of liver transplantation. Accumulating evidence suggests a significant role for gut microbiota in its development and progression. Here we review the effect of gut microbiota on developing hepatic fatty infiltration and its progression. Current literature supports a possible role for gut microbiota in the development of liver steatosis, inflammation and fibrosis. We also review the literature on possible interventions for NAFLD that target the gut microbiota.

Entities:  

Keywords:  Fibrosis; Inflammation; Microbiota and intestinal permeability; NAFLD; NASH; Steatosis

Mesh:

Year:  2016        PMID: 26898658     DOI: 10.1007/s10620-016-4045-1

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  127 in total

Review 1.  Recognition of pathogen-associated molecular patterns by TLR family.

Authors:  Shizuo Akira; Hiroaki Hemmi
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

2.  Anaerobic dissimilation of glucose-C14 by Escherichia coli.

Authors:  L M PAEGE; M GIBBS
Journal:  J Bacteriol       Date:  1961-01       Impact factor: 3.490

3.  Bile acid is a host factor that regulates the composition of the cecal microbiota in rats.

Authors:  K B M Saiful Islam; Satoru Fukiya; Masahito Hagio; Nobuyuki Fujii; Satoshi Ishizuka; Tadasuke Ooka; Yoshitoshi Ogura; Tetsuya Hayashi; Atsushi Yokota
Journal:  Gastroenterology       Date:  2011-08-10       Impact factor: 22.682

Review 4.  Role of phosphatidylcholine biosynthesis in the regulation of lipoprotein homeostasis.

Authors:  Dennis E Vance
Journal:  Curr Opin Lipidol       Date:  2008-06       Impact factor: 4.776

5.  Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease.

Authors:  Venkatanarayana Gangarapu; Ali Tüzün Ince; Birol Baysal; Yusuf Kayar; Ulkan Kılıç; Özlem Gök; Ömer Uysal; Hakan Şenturk
Journal:  Eur J Gastroenterol Hepatol       Date:  2015-07       Impact factor: 2.566

6.  Synbiotic supplementation in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled pilot study.

Authors:  Tannaz Eslamparast; Hossein Poustchi; Farhad Zamani; Maryam Sharafkhah; Reza Malekzadeh; Azita Hekmatdoost
Journal:  Am J Clin Nutr       Date:  2014-01-08       Impact factor: 7.045

7.  Correlation of vitamin E, uric acid, and diet composition with histologic features of pediatric NAFLD.

Authors:  Miriam B Vos; Ryan Colvin; Patricia Belt; Jean P Molleston; Karen F Murray; Philip Rosenthal; Jeffrey B Schwimmer; James Tonascia; Aynur Unalp; Joel E Lavine
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-01       Impact factor: 2.839

8.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

Review 9.  Does fructose consumption contribute to non-alcoholic fatty liver disease?

Authors:  Luc Tappy; Kim-Anne Lê
Journal:  Clin Res Hepatol Gastroenterol       Date:  2012-07-12       Impact factor: 2.947

10.  Endotoxemia unrequired in the pathogenesis of pediatric nonalcoholic steatohepatitis.

Authors:  Jianye Yuan; Susan S Baker; Wensheng Liu; Razan Alkhouri; Robert D Baker; Jianqun Xie; Guang Ji; Lixin Zhu
Journal:  J Gastroenterol Hepatol       Date:  2014-06       Impact factor: 4.029

View more
  15 in total

Review 1.  Food additives, contaminants and other minor components: effects on human gut microbiota-a review.

Authors:  Paula Roca-Saavedra; Veronica Mendez-Vilabrille; Jose Manuel Miranda; Carolina Nebot; Alejandra Cardelle-Cobas; Carlos M Franco; Alberto Cepeda
Journal:  J Physiol Biochem       Date:  2017-05-09       Impact factor: 4.158

2.  Influence of food consumption patterns and Galician lifestyle on human gut microbiota.

Authors:  María Castro-Penalonga; Paula Roca-Saavedra; Jose Manuel Miranda; Jose Julio Porto-Arias; Carolina Nebot; Alejandra Cardelle-Cobas; Carlos Manuel Franco; Alberto Cepeda
Journal:  J Physiol Biochem       Date:  2017-06-17       Impact factor: 4.158

Review 3.  Metabolic aspects of adult patients with nonalcoholic fatty liver disease.

Authors:  Ludovico Abenavoli; Natasa Milic; Laura Di Renzo; Tomislav Preveden; Milica Medić-Stojanoska; Antonino De Lorenzo
Journal:  World J Gastroenterol       Date:  2016-08-21       Impact factor: 5.742

Review 4.  Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota.

Authors:  Sena Bluemel; Brandon Williams; Rob Knight; Bernd Schnabl
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-29       Impact factor: 4.052

5.  Obese Adolescents With PCOS Have Altered Biodiversity and Relative Abundance in Gastrointestinal Microbiota.

Authors:  Beza Jobira; Daniel N Frank; Laura Pyle; Lori J Silveira; Megan M Kelsey; Yesenia Garcia-Reyes; Charles E Robertson; Diana Ir; Kristen J Nadeau; Melanie Cree-Green
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

6.  Circulating microbiota-derived metabolites: a "liquid biopsy?

Authors:  Gemma Aragonès; Marina Colom-Pellicer; Carmen Aguilar; Esther Guiu-Jurado; Salomé Martínez; Fàtima Sabench; José Antonio Porras; David Riesco; Daniel Del Castillo; Cristóbal Richart; Teresa Auguet
Journal:  Int J Obes (Lond)       Date:  2019-08-06       Impact factor: 5.095

Review 7.  Gut-Liver Axis Derangement in Non-Alcoholic Fatty Liver Disease.

Authors:  Marco Poeta; Luca Pierri; Pietro Vajro
Journal:  Children (Basel)       Date:  2017-08-02

Review 8.  Gut Microbiota Modulation for Multidrug-Resistant Organism Decolonization: Present and Future Perspectives.

Authors:  Livia Gargiullo; Federica Del Chierico; Patrizia D'Argenio; Lorenza Putignani
Journal:  Front Microbiol       Date:  2019-07-25       Impact factor: 5.640

9.  Elevated oxysterol levels in human and mouse livers reflect nonalcoholic steatohepatitis.

Authors:  Tina Raselli; Tom Hearn; Annika Wyss; Kirstin Atrott; Alain Peter; Isabelle Frey-Wagner; Marianne R Spalinger; Ewerton M Maggio; Andreas W Sailer; Johannes Schmitt; Philipp Schreiner; Anja Moncsek; Joachim Mertens; Michael Scharl; William J Griffiths; Marco Bueter; Andreas Geier; Gerhard Rogler; Yuqin Wang; Benjamin Misselwitz
Journal:  J Lipid Res       Date:  2019-05-21       Impact factor: 5.922

10.  Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma.

Authors:  Qisha Liu; Fan Li; Yaoyao Zhuang; Jian Xu; Jianwei Wang; Xuhua Mao; Yewei Zhang; Xingyin Liu
Journal:  Gut Pathog       Date:  2019-01-18       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.